Valeant Pharmaceuticals reported $1.23B in Operating Expenses for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Amgen AMGN:US USD 4.61B 695M
Ani Pharmaceuticals ANIP:US USD 88.82M 2.05M
Aurora Cannabis Inc ACB:CN CAD 103.76M 571.03M
Biogen BIIB:US USD 1.19B 1.45B
Bristol Myers Squibb BMY:US USD 9.46B 716M
Canopy Growth Corp WEED:CN CAD 277.53M 1.69B
Catalent CTLT:US USD 962M 105M
Corcept Therapeutics CORT:US USD 69.79M 2.16M
Danaher DHR:US USD 6.07B 425M
Drreddys Laboratories RDY:US INR 51.28B 4.35B
Eli Lilly And LLY:US USD 5.47B 200.3M
Endo International Ordinary Shares ENDP:US USD 1.18B 1.13B
Gilead Sciences GILD:US USD 5.12B 917M
Horizon Pharma HZNP:US USD 764.75M 23.1M
Nektar Therapeutics NKTR:US USD 77.93M 96.49M
Pacira Pharmaceuticals PCRX:US USD 146.18M 8M
Perrigo Ordinary Shares PRGO:US USD 1.07B 71.2M
Prestige Brands PBH:US USD 188.34M 16.55M
Revance Therapeutics RVNC:US USD 106.5M 20.29M
Supernus Pharmaceuticals SUPN:US USD 178.88M 20.17M
Valeant Pharmaceuticals VRX:CN USD 1.23B 461M
Vertex Pharmaceuticals VRTX:US USD 1.21B 117.7M
Zoetis ZTS:US USD 1.34B 47M